Status:
COMPLETED
Can the Electronic Nose Smell COVID-19?
Lead Sponsor:
Maastricht University Medical Center
Conditions:
SARS-CoV Infection
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Infection with SARS-CoV-2 causes Corona Virus Disease (COVID-19). The most standard diagnostic method is reverse transcription-polymerase chain reaction (RT-PCR) on a nasopharyngeal and/or an orophary...
Eligibility Criteria
Inclusion
- Participants of whom an oropharyngeal or nasopharyngeal swab was collected to perform RT-PCR on.
Exclusion
- Participants who were experiencing dyspnea or needed supplemental oxygen.
Key Trial Info
Start Date :
April 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT04475562
Start Date
April 6 2020
End Date
July 1 2020
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Netherlands, 6229 HX